COVID-19 Clinical Trials in New York

Showing 61-80 of 212 trials

Impact of COVID-19 on GU Disease

NCT04761107

The purpose of this research study is to identify patients with GU disease with active or past COVID-19 infection. Participants will be asked to: * Complete an Online COVID-19 Questionnaire. * Disclose if the patient has or had Genitourinary cancer or benign urologic condition * Provide urine specimen for research * Provide 4 tablespoons of blood for testing blood for research. * Provide permission to access medical records, such as patient lab results, medical history, imaging reports, etc.

COVID-19 InfectionGenitourinary CancerBenign Urologic Conditions

Icahn School of Medicine at Mount Sinai15,240 participantsStarted Feb 2021

New York, New York, United States

COMPLETEDPhase 2/3< 1 mile

Novel Experimental COVID-19 Therapies Affecting Host Response

NCT04924660

The overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients hospitalized for COVID-19 include hastening recovery and preventing progression to critical illness, multiorgan failure, or death. Our objective is to determine whether modulating the host tissue response improves clinical outcomes among patients with COVID-19. The primary analysis will include data from NCT05593770.

COVID-19SARS-CoV-2 InfectionCoronavirus Infection

Sean Collins1,060 participantsStarted Jul 2021

Birmingham, Alabama, United States • Chandler, Arizona, United States • Los Angeles, California, United States +48 more locations

Impact of COVID-19 on GU Disease

Novel Experimental COVID-19 Therapies Affecting Host Response

COVID-19 Trials in Other Cities

IMM-BCP-01 in Mild to Moderate COVID-19

Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)

This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.

Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization

Methodologies for Observational Studies Comparing Inpatient COVID-19 Treatments

Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19)

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

COVID-19 Vaccine Response in Sickle Cell Disease

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

A Study of Ad26.COV2.S in Adults (COVID-19)

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

Other Conditions in New York